Status:

COMPLETED

Physiologic Regulation of FGF-23

Lead Sponsor:

National Institute of Dental and Craniofacial Research (NIDCR)

Conditions:

Hypoparathyroidism

Eligibility:

All Genders

18+ years

Brief Summary

This study will explore the regulation of fibroblast growth factor-23 (FGF-23). It is a hormone recently identified as a regulator of the blood levels of phosphorus and vitamin D, both of which are es...

Detailed Description

Vitamin D and phosphate are central to normal mineral homeostasis and important in many physiologic functions including skeletal integrity. For several decades parathyroid hormone (PTH) has been recog...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • Adult hypoparathyroid patients, as defined by low or inappropriately normal PTH levels despite hypocalcemia, who are on a stable treatment regimen of calcitriol and calcium supplementation, and who are willing to participate in the study will be eligible.
  • Adult PHP1B patients as defined by the clinical syndrome of elevated PTH and phosphorus and confirmed by methylation analysis of the GNAS gene.
  • EXCLUSION CRITERIA
  • Renal insufficiency as evidenced by a creatinine clearance of less than 50 ml/min
  • Medically unstable patients
  • Uncontrolled comorbid conditions, e.g., diabetes, coronary artery disease, congestive heart failure, or cerebrovascular disease.
  • Digitalis therapy
  • Patients on diuretic therapy, especially thiazides
  • Pregnant and lactating women
  • Patients whose hypoparathyroidism is caused by severe calcium-sensing receptor defects. These patients begin to have marked symptoms of "hypercalcemia" when the serum calcium is in the mid-normal range.
  • Patients under 18 years of age
  • Patients with history of any bone cancer, skeletal metastases or previous radiotherapy to the skeleton, unexplained elevations of serum alkaline phosphatase

Exclusion

    Key Trial Info

    Start Date :

    July 19 2006

    Trial Type :

    OBSERVATIONAL

    End Date :

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT00356512

    Start Date

    July 19 2006

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892